Inveready leads a €3.5 Million round in Leukos Biotech, a

The principal Investigator Ruth M. Risueño will lead the development of a new class of drugs against Leukemia Stem Cells.

News  September 21, 2016
Publication  November 20, 2014
  NEXT  
Copyright © 2010 Antares Consulting S.A. All rights reserved   |   Terms of use   |   Privacy Police